An investment in Santhera shares (“Shares”) involves a high degree of risk. Prospective investors should carefully consider the risks related to any investment in the Shares before making a decision to invest in the Shares. The risks described below are not the only ones applicable to Santhera Pharmaceuticals Holding AG (the “Company”) and/or its subsidiaries (together with the Company, the “Group”, “Santhera", "we" or "us"). Additional risks not presently known or currently deemed immaterial may also impair the Group’s business, results of operations, financial condition or prospects. The realization of one or more of these risks individually or together with other circumstances may have a material adverse effect on the Group’s business, results of operations, financial condition or prospects. In addition, each of the risks set out below could adversely affect the trading price of the Shares, and investors in Shares may lose all or a part of their investment.
The order in which the risks are presented below is not intended to indicate the probability of their occurrence or the materiality of the risk.
By issuing these risk factors, we do not promote or solicit any investment in the Shares or related securities.
Datum: 27. September 2021